Dr Manaf Al Matar

Sohar University > Dr Manaf Al Matar

Dr Manaf Al Matar

Assistant Professor
mmatar@su.edu.om
Phone: +968 26850100
Extn: 306
Location: Barka building

GoogleScholar ORCID

Biography

Manaf AlMatar holds a Ph.D. in biotechnology from the Ukurova University in Turkey. Prior to joining Sohar University in Oman, he was a postdoctoral researcher at the University of Malaysia Pahang in Malaysia. He has published multiple articles in high-impact journals on a variety of issues, including gene expression, new antibiotics, infectious diseases, and more.

Qualification

  • Ph.D. in Biotechnology, Cukurova university, ​Turkey, 2018.
  • M.Sc. in Biotechnology, Universiti Teknologi Malaysia (UTM), Malaysia, 2013.
  • Bachelor in Biology (Microbiology), Aleppo University, Syria, 2008.

Teaching Interest

  • ​​Medical Microbiology
  • ​​Molecular Microbiology
  • ​​Tuberculosis
  • ​​Genetic

Research Interest

  • Infectious disease
  • Medical Microbiology
  • Molecular Biology
  • Natural products

Publications

  • AlMatar, M., Makky, E., Mazila Ramli AN., Kafkas E., Koksal, F (2022). Polysaccharides to combat viruses (Covid-19) and microbes: New updates.Current Molecular Pharmacology, 15(6):803-814. DOi: 10.2174/1874467215666220112150332
  • Makky, E. A., AlMatar, M., Mahmood, M. H., Wen, K. X., & Qi, T. B. G. (2022). In-vitro antioxidant and antimicrobial studies of ethanolic plant extracts of P. granatum, O. stamineus, A. bilimbi, M. nigra, and E. longifolia. Current Pharmaceutical Biotechnology;23(10):1284-1312. Doi: 10.2174/1389201022666210615113854.
  • AlMatar, M., Albarri, O., Makky, E. A., & Köksal, F. (2021). Efflux pump inhibitors: new updates. Pharmacological Reports, 73(1), 1-16. Doi: 10.1007/s43440-020-00160-9.​
  • AlMatar, M., Albarri, O., Makky, E. A., Var, I., & Köksal, F. (2020). A Glance on the Role of Bacterial Siderophore from the Perspectives of Medical and Biotechnological Approaches. Current drug targets, 21(13), 1326-1343.
  • AlMatar, M., Var, I., Kayar, B., & Köksal, F. (2020). Differential expression of resistant and efflux pump genes in MDR-TB isolates. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders), 20(2), 271-287.
  • AlMatar, M., Albarri, O., Makky, E. A., Var, I., & Kl, F. (2020). An Overview of the Activities of Cefiderocol Against Sensitive and Multidrug-Resistant (MDR) Bacteria. Mini reviews in medicinal chemistry, 20(18), 1908-1916.
  • AlMatar, M., Var, I., Kayar, B., Eker, E., Kafkas, E., Zarifikhosroshahi, M., & Köksal, F. (2019). Evaluation of polyphenolic profile and antibacterial activity of pomegranate juice in combination with rifampin (R) against MDR-TB clinical isolates. Current pharmaceutical biotechnology, 20(4), 317-326.
  • AlMatar, M., Makky, E. A., AlMandeal, H., Eker, E., Kayar, B., Var, I., & Köksal, F. (2019). Does the development of vaccines advance solutions for tuberculosis?. Current molecular pharmacology, 12(2), 83-104.​
  • AlMatar, M., Makky, E. A., Var, I., & Koksal, F. (2018). The role of nanoparticles in the inhibition of multidrug-resistant bacteria and biofilms. Current drug delivery, 15(4), 470-484.
  • AlMatar, M., Islam, M. R., Albarri, O., Var, I., & Koksal, F. (2018). Pomegranate as a possible treatment in reducing risk of developing wound healing, obesity, neurodegenerative disorders, and diabetes mellitus. Mini reviews in medicinal chemistry, 18(6), 507-526.
  • AlMatar, M., Makky, E. A., Var, I., Kayar, B., & Köksal, F. (2018). Novel compounds targeting InhA for TB therapy. Pharmacological Reports, 70(2), 217-226.
  • AlMatar, M., Makky, E. A., Yakıcı, G., Var, I., Kayar, B., & Köksal, F. (2018). Antimicrobial peptides as an alternative to anti-tuberculosis drugs. Pharmacological research, 128, 288-305.
  • AlMatar, M., AlMandeal, H., Var, I., Kayar, B., & Köksal, F. (2017). New drugs for the treatment of Mycobacterium tuberculosis infection. Biomedicine & Pharmacotherapy, 91, 546-558.
  • AlMatar, M., AlMandeal, H., A Makky, E., Kayar, B., Yarar, E., Var, I., & Koksal, F. (2017). The physiological/pathophysiological significance of Vitamin D in cancer, cardiovascular disorders and beyond. Current drug metabolism, 18(3), 207-224.
  • AlMatar, M., Eldeeb, M., Makky, E. A., Köksal, F., Var, I., & Kayar, B. (2017). Are there any other compounds isolated from Dermacoccus spp at all?. Current microbiology, 74(1), 132-144.
  • IM Al-Astal, H., Massad, M., AlMatar, M., & Ekal, H. (2016). Cellular functions of RNA-binding motif protein 3 (RBM3): clues in hypothermia, cancer biology and apoptosis. Protein and peptide letters, 23(9), 828-835.
  • AlMatar, M., & Makky, E. A. (2016). Cladosporium cladosporioides from the perspectives of medical and biotechnological approaches. 3 Biotech, 6(1), 4.
  • AlMatar, M., Batool, T., & A Makky, E. (2016). Therapeutic potential of N-acetylcysteine for wound healing, acute bronchiolitis, and congenital heart defects. Current drug metabolism, 17(2), 156-167.
  • AlMatar, M., Var, I., & Koksal, F. (2016). How Does Alternaria alternata-Derived Alternariol Affect Our Health?. Mini-Reviews in Organic Chemistry, 13(6), 465-472.

Journal Articles